BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29305738)

  • 21. Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma.
    Shim SJ; Seong J; Han KH; Chon CY; Suh CO; Lee JT
    Liver Int; 2005 Dec; 25(6):1189-96. PubMed ID: 16343071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimodality treatment with conventional transcatheter arterial chemoembolization and radiofrequency ablation for unresectable hepatocellular carcinoma.
    Ashoori N; Paprottka P; Trumm C; Bamberg F; Kolligs FT; Rentsch M; Reiser MF; Jakobs TF
    Digestion; 2012; 85(1):18-26. PubMed ID: 22156507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC).
    Lin XJ; Li QJ; Lao XM; Yang H; Li SP
    BMC Cancer; 2015 Oct; 15():707. PubMed ID: 26470869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of endoscopic biliary stenting for obstructive jaundice caused by hepatocellular carcinoma.
    Sugiyama G; Okabe Y; Ishida Y; Saitou F; Kawahara R; Ishikawa H; Horiuchi H; Kinoshita H; Tsuruta O; Sata M
    World J Gastroenterol; 2014 Jun; 20(22):6968-73. PubMed ID: 24944490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.
    Kim JH; Yoon HK; Kim SY; Kim KM; Ko GY; Gwon DI; Sung KB
    Aliment Pharmacol Ther; 2009 Jun; 29(12):1291-8. PubMed ID: 19392861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locally advanced pancreatic carcinoma with jaundice: the benefit of a sequential treatment with stenting followed by CT-guided
    Chen C; Wang W; Wang W; Wang Y; Yu Z; Li Y
    Eur Radiol; 2021 Sep; 31(9):6500-6510. PubMed ID: 33630162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
.
    Huang Y; Chen B; Liu N; Li N; Dao H; Chen W; Yang J
    Int J Clin Pharmacol Ther; 2017 Jun; 55(6):498-508. PubMed ID: 28157070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Li L; Tian J; Liu P; Wang X; Zhu Z
    Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of transcatheter arterial chemoembolization with embospheres in treatment of hepatocellular carcinoma.
    Hao MZ; Lin HL; Chen QZ; Hu YB; Chen JB; Zheng JX; Zhou D; Zhang H
    J Dig Dis; 2017 Jan; 18(1):31-39. PubMed ID: 27987344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sorafenib with TACE improves the survival of hepatocellular carcinoma patients with more than 10 cm tumor: a single-center retrospective study.
    Aktas G; Kus T; Emin Kalender M; Kervancioglu S; Sevinc A; Kul S; Camci C
    J BUON; 2017; 22(1):150-156. PubMed ID: 28365948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic artery injection of ¹³¹I-labelled metuximab combined with chemoembolization for intermediate hepatocellular carcinoma: a prospective nonrandomized study.
    Wu L; Yang YF; Ge NJ; Shen SQ; Liang J; Wang Y; Zhou WP; Shen F; Wu MC
    Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1306-15. PubMed ID: 22588627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
    Li CX; Wu PH; Fan WJ; Huang JH; Zhang FJ; Zhang L; Gu YK; Zhao M; Gao F; Jiao DC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(11):754-7. PubMed ID: 19595104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study.
    Lee HS; Kim KM; Yoon JH; Lee TR; Suh KS; Lee KU; Chung JW; Park JH; Kim CY
    J Clin Oncol; 2002 Nov; 20(22):4459-65. PubMed ID: 12431969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group.
    Farinati F; Vanin V; Giacomin A; Pozzan C; Cillo U; Vitale A; Di Nolfo AM; Del Poggio P; Benvegnu' L; Rapaccini G; Zoli M; Borzio F; Giannini EG; Caturelli E; Trevisani F;
    Liver Int; 2015 Jan; 35(1):223-31. PubMed ID: 25074434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC.
    Prajapati HJ; Xing M; Spivey JR; Hanish SI; El-Rayes BF; Kauh JS; Chen Z; Kim HS
    AJR Am J Roentgenol; 2014 Dec; 203(6):W706-14. PubMed ID: 25415737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of transcatheter arterial chemoembolization combined thalidomide on hepatocellular carcinoma: a controlled randomized trial].
    Hao MZ; Lin HL; Chen Q; Wu H; Yu WC; Chen TG
    Ai Zheng; 2007 Aug; 26(8):861-5. PubMed ID: 17697548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portal Vein Stenting Combined with Iodine-125 Seeds Endovascular Implantation Followed by Transcatheter Arterial Chemoembolization for Treatment of Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus.
    Sun JH; Zhou T; Zhu T; Zhang Y; Nie C; Ai J; Zhou G; Zhang A; Dong MJ; Wang WL; Zheng SS
    Biomed Res Int; 2016; 2016():3048261. PubMed ID: 27999793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of therapeutic effectiveness and prognostic factor on argon-helium cryoablation combined with transcatheter arterial chemoembolization for the treatment of advanced hepatocellular carcinoma.
    Huang C; Zhuang W; Feng H; Guo H; Tang Y; Chen H; Huang Y
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C148-C152. PubMed ID: 28230008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular carcinoma invading the main portal vein: treatment with transcatheter arterial chemoembolization and portal vein stenting.
    Zhang XB; Wang JH; Yan ZP; Qian S; Liu R
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):52-61. PubMed ID: 18931871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.